nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—GNRHR—hindbrain—brain cancer	0.0344	0.2	CbGeAlD
Goserelin—LHCGR—gonad—brain cancer	0.0227	0.132	CbGeAlD
Goserelin—GNRHR—brainstem—brain cancer	0.0197	0.114	CbGeAlD
Goserelin—LHCGR—endocrine gland—brain cancer	0.0171	0.0994	CbGeAlD
Goserelin—GNRHR—gonad—brain cancer	0.0146	0.0848	CbGeAlD
Goserelin—GNRHR—pituitary gland—brain cancer	0.0142	0.0827	CbGeAlD
Goserelin—GNRHR—endocrine gland—brain cancer	0.011	0.0641	CbGeAlD
Goserelin—GNRHR—head—brain cancer	0.0109	0.0633	CbGeAlD
Goserelin—GNRHR—central nervous system—brain cancer	0.00994	0.0577	CbGeAlD
Goserelin—LHCGR—Ovarian Infertility Genes—ESR2—brain cancer	0.00985	0.0994	CbGpPWpGaD
Goserelin—GNRHR—cerebellum—brain cancer	0.00972	0.0564	CbGeAlD
Goserelin—GNRHR—brain—brain cancer	0.00789	0.0458	CbGeAlD
Goserelin—LHCGR—Ovarian Infertility Genes—CDK4—brain cancer	0.006	0.0606	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—SMO—brain cancer	0.00339	0.0342	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTCH2—brain cancer	0.00293	0.0296	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—EGFR—brain cancer	0.00283	0.0286	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—OR4C12—brain cancer	0.00257	0.026	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—OR14C36—brain cancer	0.00257	0.026	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—OR4C12—brain cancer	0.00234	0.0236	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—OR14C36—brain cancer	0.00234	0.0236	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTCH2—brain cancer	0.00196	0.0198	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—TRPC6—brain cancer	0.00194	0.0195	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00173	0.0175	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—OR14C36—brain cancer	0.00172	0.0174	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—OR4C12—brain cancer	0.00172	0.0174	CbGpPWpGaD
Goserelin—Dysuria—Temozolomide—brain cancer	0.00169	0.00232	CcSEcCtD
Goserelin—Infection—Procarbazine—brain cancer	0.00169	0.00231	CcSEcCtD
Goserelin—Hyperglycaemia—Carmustine—brain cancer	0.00168	0.00231	CcSEcCtD
Goserelin—Angiopathy—Hydroxyurea—brain cancer	0.00168	0.0023	CcSEcCtD
Goserelin—Upper respiratory tract infection—Temozolomide—brain cancer	0.00168	0.0023	CcSEcCtD
Goserelin—Pneumonia—Carmustine—brain cancer	0.00167	0.0023	CcSEcCtD
Goserelin—Shock—Procarbazine—brain cancer	0.00167	0.00229	CcSEcCtD
Goserelin—Pollakiuria—Temozolomide—brain cancer	0.00167	0.00229	CcSEcCtD
Goserelin—Erectile dysfunction—Temozolomide—brain cancer	0.00166	0.00228	CcSEcCtD
Goserelin—Thrombocytopenia—Procarbazine—brain cancer	0.00166	0.00228	CcSEcCtD
Goserelin—Depression—Carmustine—brain cancer	0.00166	0.00228	CcSEcCtD
Goserelin—Chills—Hydroxyurea—brain cancer	0.00166	0.00228	CcSEcCtD
Goserelin—Tachycardia—Procarbazine—brain cancer	0.00166	0.00227	CcSEcCtD
Goserelin—Photosensitivity reaction—Temozolomide—brain cancer	0.00165	0.00226	CcSEcCtD
Goserelin—Weight increased—Temozolomide—brain cancer	0.00164	0.00225	CcSEcCtD
Goserelin—Hyperhidrosis—Procarbazine—brain cancer	0.00164	0.00225	CcSEcCtD
Goserelin—Renal failure—Carmustine—brain cancer	0.00164	0.00225	CcSEcCtD
Goserelin—Alopecia—Hydroxyurea—brain cancer	0.00163	0.00224	CcSEcCtD
Goserelin—Hyperglycaemia—Temozolomide—brain cancer	0.00163	0.00223	CcSEcCtD
Goserelin—Urinary tract infection—Carmustine—brain cancer	0.00162	0.00222	CcSEcCtD
Goserelin—Pneumonia—Temozolomide—brain cancer	0.00162	0.00222	CcSEcCtD
Goserelin—Anorexia—Procarbazine—brain cancer	0.00162	0.00222	CcSEcCtD
Goserelin—Erythema—Hydroxyurea—brain cancer	0.00161	0.00221	CcSEcCtD
Goserelin—Depression—Temozolomide—brain cancer	0.0016	0.0022	CcSEcCtD
Goserelin—Nausea—Lomustine—brain cancer	0.00159	0.00218	CcSEcCtD
Goserelin—Hypotension—Procarbazine—brain cancer	0.00159	0.00218	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—OR4C12—brain cancer	0.00156	0.0158	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—OR14C36—brain cancer	0.00156	0.0158	CbGpPWpGaD
Goserelin—Urinary tract infection—Temozolomide—brain cancer	0.00156	0.00215	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00155	0.00212	CcSEcCtD
Goserelin—Insomnia—Procarbazine—brain cancer	0.00154	0.00211	CcSEcCtD
Goserelin—Paraesthesia—Procarbazine—brain cancer	0.00152	0.00209	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—SHH—brain cancer	0.00151	0.0153	CbGpPWpGaD
Goserelin—Sinusitis—Temozolomide—brain cancer	0.00151	0.00207	CcSEcCtD
Goserelin—Somnolence—Procarbazine—brain cancer	0.00151	0.00207	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PTCH2—brain cancer	0.00151	0.0152	CbGpPWpGaD
Goserelin—Haemoglobin—Carmustine—brain cancer	0.0015	0.00206	CcSEcCtD
Goserelin—Haemorrhage—Carmustine—brain cancer	0.00149	0.00205	CcSEcCtD
Goserelin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00149	0.00205	CcSEcCtD
Goserelin—Anaemia—Hydroxyurea—brain cancer	0.00149	0.00204	CcSEcCtD
Goserelin—Decreased appetite—Procarbazine—brain cancer	0.00148	0.00202	CcSEcCtD
Goserelin—Oedema peripheral—Carmustine—brain cancer	0.00147	0.00202	CcSEcCtD
Goserelin—Fatigue—Procarbazine—brain cancer	0.00146	0.00201	CcSEcCtD
Goserelin—Haemoglobin—Temozolomide—brain cancer	0.00145	0.00199	CcSEcCtD
Goserelin—Malaise—Hydroxyurea—brain cancer	0.00145	0.00199	CcSEcCtD
Goserelin—Pain—Procarbazine—brain cancer	0.00145	0.00199	CcSEcCtD
Goserelin—Constipation—Procarbazine—brain cancer	0.00145	0.00199	CcSEcCtD
Goserelin—Hepatitis—Temozolomide—brain cancer	0.00144	0.00198	CcSEcCtD
Goserelin—Haemorrhage—Temozolomide—brain cancer	0.00144	0.00198	CcSEcCtD
Goserelin—Leukopenia—Hydroxyurea—brain cancer	0.00144	0.00198	CcSEcCtD
Goserelin—Pharyngitis—Temozolomide—brain cancer	0.00143	0.00197	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—SMO—brain cancer	0.00143	0.0145	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTCH1—brain cancer	0.00143	0.0145	CbGpPWpGaD
Goserelin—Urinary tract disorder—Temozolomide—brain cancer	0.00143	0.00196	CcSEcCtD
Goserelin—Oedema peripheral—Temozolomide—brain cancer	0.00142	0.00195	CcSEcCtD
Goserelin—Urethral disorder—Temozolomide—brain cancer	0.00142	0.00194	CcSEcCtD
Goserelin—Feeling abnormal—Procarbazine—brain cancer	0.0014	0.00192	CcSEcCtD
Goserelin—Eye disorder—Carmustine—brain cancer	0.0014	0.00192	CcSEcCtD
Goserelin—Convulsion—Hydroxyurea—brain cancer	0.00139	0.00191	CcSEcCtD
Goserelin—Gastrointestinal pain—Procarbazine—brain cancer	0.00139	0.0019	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—OR4C12—brain cancer	0.00138	0.0139	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—OR14C36—brain cancer	0.00138	0.0139	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00136	0.00187	CcSEcCtD
Goserelin—Discomfort—Hydroxyurea—brain cancer	0.00135	0.00186	CcSEcCtD
Goserelin—Eye disorder—Temozolomide—brain cancer	0.00135	0.00185	CcSEcCtD
Goserelin—Urticaria—Procarbazine—brain cancer	0.00135	0.00185	CcSEcCtD
Goserelin—Body temperature increased—Procarbazine—brain cancer	0.00134	0.00184	CcSEcCtD
Goserelin—Abdominal pain—Procarbazine—brain cancer	0.00134	0.00184	CcSEcCtD
Goserelin—Cardiac disorder—Temozolomide—brain cancer	0.00134	0.00184	CcSEcCtD
Goserelin—Arrhythmia—Carmustine—brain cancer	0.00134	0.00183	CcSEcCtD
Goserelin—Alopecia—Carmustine—brain cancer	0.00132	0.00181	CcSEcCtD
Goserelin—Oedema—Hydroxyurea—brain cancer	0.00131	0.0018	CcSEcCtD
Goserelin—Angiopathy—Temozolomide—brain cancer	0.00131	0.0018	CcSEcCtD
Goserelin—Mental disorder—Carmustine—brain cancer	0.00131	0.0018	CcSEcCtD
Goserelin—Infection—Hydroxyurea—brain cancer	0.0013	0.00179	CcSEcCtD
Goserelin—Immune system disorder—Temozolomide—brain cancer	0.0013	0.00179	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—ABR—brain cancer	0.0013	0.0131	CbGpPWpGaD
Goserelin—Malnutrition—Carmustine—brain cancer	0.0013	0.00179	CcSEcCtD
Goserelin—Erythema—Carmustine—brain cancer	0.0013	0.00179	CcSEcCtD
Goserelin—Chills—Temozolomide—brain cancer	0.0013	0.00178	CcSEcCtD
Goserelin—Pneumonia—Etoposide—brain cancer	0.00129	0.00178	CcSEcCtD
Goserelin—Nervous system disorder—Hydroxyurea—brain cancer	0.00129	0.00177	CcSEcCtD
Goserelin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00129	0.00176	CcSEcCtD
Goserelin—Alopecia—Temozolomide—brain cancer	0.00128	0.00175	CcSEcCtD
Goserelin—Skin disorder—Hydroxyurea—brain cancer	0.00128	0.00175	CcSEcCtD
Goserelin—Acute coronary syndrome—Etoposide—brain cancer	0.00127	0.00174	CcSEcCtD
Goserelin—Renal failure—Etoposide—brain cancer	0.00127	0.00174	CcSEcCtD
Goserelin—Mental disorder—Temozolomide—brain cancer	0.00127	0.00174	CcSEcCtD
Goserelin—Myocardial infarction—Etoposide—brain cancer	0.00126	0.00173	CcSEcCtD
Goserelin—Back pain—Carmustine—brain cancer	0.00126	0.00173	CcSEcCtD
Goserelin—Erythema—Temozolomide—brain cancer	0.00126	0.00173	CcSEcCtD
Goserelin—Malnutrition—Temozolomide—brain cancer	0.00126	0.00173	CcSEcCtD
Goserelin—Jaundice—Etoposide—brain cancer	0.00125	0.00172	CcSEcCtD
Goserelin—Anorexia—Hydroxyurea—brain cancer	0.00125	0.00172	CcSEcCtD
Goserelin—Hypersensitivity—Procarbazine—brain cancer	0.00125	0.00172	CcSEcCtD
Goserelin—Vision blurred—Carmustine—brain cancer	0.00123	0.00168	CcSEcCtD
Goserelin—Asthenia—Procarbazine—brain cancer	0.00122	0.00167	CcSEcCtD
Goserelin—Back pain—Temozolomide—brain cancer	0.00122	0.00167	CcSEcCtD
Goserelin—Anaemia—Carmustine—brain cancer	0.0012	0.00165	CcSEcCtD
Goserelin—Pruritus—Procarbazine—brain cancer	0.0012	0.00165	CcSEcCtD
Goserelin—Vision blurred—Temozolomide—brain cancer	0.00118	0.00163	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ABR—brain cancer	0.00118	0.0119	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DTX2—brain cancer	0.00117	0.0119	CbGpPWpGaD
Goserelin—Dyspnoea—Hydroxyurea—brain cancer	0.00117	0.00161	CcSEcCtD
Goserelin—Somnolence—Hydroxyurea—brain cancer	0.00117	0.0016	CcSEcCtD
Goserelin—Ill-defined disorder—Temozolomide—brain cancer	0.00117	0.0016	CcSEcCtD
Goserelin—Leukopenia—Carmustine—brain cancer	0.00116	0.0016	CcSEcCtD
Goserelin—Anaemia—Temozolomide—brain cancer	0.00116	0.00159	CcSEcCtD
Goserelin—Diarrhoea—Procarbazine—brain cancer	0.00116	0.00159	CcSEcCtD
Goserelin—Dyspepsia—Hydroxyurea—brain cancer	0.00116	0.00159	CcSEcCtD
Goserelin—Decreased appetite—Hydroxyurea—brain cancer	0.00114	0.00157	CcSEcCtD
Goserelin—Urinary tract disorder—Etoposide—brain cancer	0.00114	0.00157	CcSEcCtD
Goserelin—Malaise—Temozolomide—brain cancer	0.00113	0.00156	CcSEcCtD
Goserelin—Urethral disorder—Etoposide—brain cancer	0.00113	0.00155	CcSEcCtD
Goserelin—Fatigue—Hydroxyurea—brain cancer	0.00113	0.00155	CcSEcCtD
Goserelin—Convulsion—Carmustine—brain cancer	0.00113	0.00155	CcSEcCtD
Goserelin—Leukopenia—Temozolomide—brain cancer	0.00113	0.00154	CcSEcCtD
Goserelin—Hypertension—Carmustine—brain cancer	0.00112	0.00154	CcSEcCtD
Goserelin—Pain—Hydroxyurea—brain cancer	0.00112	0.00154	CcSEcCtD
Goserelin—Constipation—Hydroxyurea—brain cancer	0.00112	0.00154	CcSEcCtD
Goserelin—Dizziness—Procarbazine—brain cancer	0.00112	0.00154	CcSEcCtD
Goserelin—Palpitations—Temozolomide—brain cancer	0.00111	0.00152	CcSEcCtD
Goserelin—Myalgia—Carmustine—brain cancer	0.00111	0.00152	CcSEcCtD
Goserelin—Chest pain—Carmustine—brain cancer	0.00111	0.00152	CcSEcCtD
Goserelin—Anxiety—Carmustine—brain cancer	0.0011	0.00151	CcSEcCtD
Goserelin—Cough—Temozolomide—brain cancer	0.0011	0.00151	CcSEcCtD
Goserelin—Convulsion—Temozolomide—brain cancer	0.00109	0.00149	CcSEcCtD
Goserelin—Hypertension—Temozolomide—brain cancer	0.00109	0.00149	CcSEcCtD
Goserelin—Feeling abnormal—Hydroxyurea—brain cancer	0.00108	0.00149	CcSEcCtD
Goserelin—Eye disorder—Etoposide—brain cancer	0.00108	0.00148	CcSEcCtD
Goserelin—Vomiting—Procarbazine—brain cancer	0.00108	0.00148	CcSEcCtD
Goserelin—Cardiac disorder—Etoposide—brain cancer	0.00107	0.00147	CcSEcCtD
Goserelin—Confusional state—Carmustine—brain cancer	0.00107	0.00147	CcSEcCtD
Goserelin—Arthralgia—Temozolomide—brain cancer	0.00107	0.00147	CcSEcCtD
Goserelin—Myalgia—Temozolomide—brain cancer	0.00107	0.00147	CcSEcCtD
Goserelin—Rash—Procarbazine—brain cancer	0.00107	0.00147	CcSEcCtD
Goserelin—Dermatitis—Procarbazine—brain cancer	0.00107	0.00147	CcSEcCtD
Goserelin—Anxiety—Temozolomide—brain cancer	0.00107	0.00146	CcSEcCtD
Goserelin—Headache—Procarbazine—brain cancer	0.00106	0.00146	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00106	0.00146	CcSEcCtD
Goserelin—Oedema—Carmustine—brain cancer	0.00106	0.00146	CcSEcCtD
Goserelin—Discomfort—Temozolomide—brain cancer	0.00106	0.00145	CcSEcCtD
Goserelin—Infection—Carmustine—brain cancer	0.00105	0.00145	CcSEcCtD
Goserelin—Angiopathy—Etoposide—brain cancer	0.00105	0.00144	CcSEcCtD
Goserelin—Dry mouth—Temozolomide—brain cancer	0.00105	0.00144	CcSEcCtD
Goserelin—Immune system disorder—Etoposide—brain cancer	0.00104	0.00143	CcSEcCtD
Goserelin—Thrombocytopenia—Carmustine—brain cancer	0.00104	0.00143	CcSEcCtD
Goserelin—Body temperature increased—Hydroxyurea—brain cancer	0.00104	0.00142	CcSEcCtD
Goserelin—Chills—Etoposide—brain cancer	0.00104	0.00142	CcSEcCtD
Goserelin—Tachycardia—Carmustine—brain cancer	0.00104	0.00142	CcSEcCtD
Goserelin—Confusional state—Temozolomide—brain cancer	0.00103	0.00142	CcSEcCtD
Goserelin—Oedema—Temozolomide—brain cancer	0.00103	0.00141	CcSEcCtD
Goserelin—Anaphylactic shock—Temozolomide—brain cancer	0.00103	0.00141	CcSEcCtD
Goserelin—Alopecia—Etoposide—brain cancer	0.00102	0.0014	CcSEcCtD
Goserelin—Infection—Temozolomide—brain cancer	0.00102	0.0014	CcSEcCtD
Goserelin—Anorexia—Carmustine—brain cancer	0.00101	0.00139	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—SHH—brain cancer	0.00101	0.0102	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTCH2—brain cancer	0.00101	0.0102	CbGpPWpGaD
Goserelin—Nausea—Procarbazine—brain cancer	0.00101	0.00138	CcSEcCtD
Goserelin—Nervous system disorder—Temozolomide—brain cancer	0.00101	0.00138	CcSEcCtD
Goserelin—Thrombocytopenia—Temozolomide—brain cancer	0.001	0.00138	CcSEcCtD
Goserelin—Skin disorder—Temozolomide—brain cancer	0.000997	0.00137	CcSEcCtD
Goserelin—Hypotension—Carmustine—brain cancer	0.000992	0.00136	CcSEcCtD
Goserelin—Hyperhidrosis—Temozolomide—brain cancer	0.000992	0.00136	CcSEcCtD
Goserelin—Anorexia—Temozolomide—brain cancer	0.000978	0.00134	CcSEcCtD
Goserelin—Back pain—Etoposide—brain cancer	0.000973	0.00134	CcSEcCtD
Goserelin—Hypersensitivity—Hydroxyurea—brain cancer	0.000968	0.00133	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000967	0.00133	CcSEcCtD
Goserelin—Muscle spasms—Etoposide—brain cancer	0.000967	0.00133	CcSEcCtD
Goserelin—Insomnia—Carmustine—brain cancer	0.00096	0.00132	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—SMO—brain cancer	0.000959	0.00969	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTCH1—brain cancer	0.000959	0.00969	CbGpPWpGaD
Goserelin—Paraesthesia—Carmustine—brain cancer	0.000954	0.00131	CcSEcCtD
Goserelin—Dyspnoea—Carmustine—brain cancer	0.000947	0.0013	CcSEcCtD
Goserelin—Somnolence—Carmustine—brain cancer	0.000944	0.0013	CcSEcCtD
Goserelin—Asthenia—Hydroxyurea—brain cancer	0.000942	0.00129	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000935	0.00128	CcSEcCtD
Goserelin—Ill-defined disorder—Etoposide—brain cancer	0.000934	0.00128	CcSEcCtD
Goserelin—Anaemia—Etoposide—brain cancer	0.00093	0.00128	CcSEcCtD
Goserelin—Insomnia—Temozolomide—brain cancer	0.000928	0.00127	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—OR14C36—brain cancer	0.000924	0.00933	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—OR4C12—brain cancer	0.000924	0.00933	CbGpPWpGaD
Goserelin—Decreased appetite—Carmustine—brain cancer	0.000923	0.00127	CcSEcCtD
Goserelin—Paraesthesia—Temozolomide—brain cancer	0.000921	0.00126	CcSEcCtD
Goserelin—Dyspnoea—Temozolomide—brain cancer	0.000915	0.00126	CcSEcCtD
Goserelin—Somnolence—Temozolomide—brain cancer	0.000912	0.00125	CcSEcCtD
Goserelin—Pain—Carmustine—brain cancer	0.000908	0.00125	CcSEcCtD
Goserelin—Constipation—Carmustine—brain cancer	0.000908	0.00125	CcSEcCtD
Goserelin—Malaise—Etoposide—brain cancer	0.000907	0.00124	CcSEcCtD
Goserelin—Dyspepsia—Temozolomide—brain cancer	0.000903	0.00124	CcSEcCtD
Goserelin—Leukopenia—Etoposide—brain cancer	0.000901	0.00124	CcSEcCtD
Goserelin—Diarrhoea—Hydroxyurea—brain cancer	0.000899	0.00123	CcSEcCtD
Goserelin—Decreased appetite—Temozolomide—brain cancer	0.000892	0.00122	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PTCH2—brain cancer	0.00089	0.00898	CbGpPWpGaD
Goserelin—Fatigue—Temozolomide—brain cancer	0.000885	0.00121	CcSEcCtD
Goserelin—Cough—Etoposide—brain cancer	0.000878	0.0012	CcSEcCtD
Goserelin—Pain—Temozolomide—brain cancer	0.000878	0.0012	CcSEcCtD
Goserelin—Constipation—Temozolomide—brain cancer	0.000878	0.0012	CcSEcCtD
Goserelin—Feeling abnormal—Carmustine—brain cancer	0.000875	0.0012	CcSEcCtD
Goserelin—Convulsion—Etoposide—brain cancer	0.000872	0.0012	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—ABR—brain cancer	0.000871	0.0088	CbGpPWpGaD
Goserelin—Hypertension—Etoposide—brain cancer	0.000869	0.00119	CcSEcCtD
Goserelin—Dizziness—Hydroxyurea—brain cancer	0.000869	0.00119	CcSEcCtD
Goserelin—Gastrointestinal pain—Carmustine—brain cancer	0.000868	0.00119	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HES5—brain cancer	0.000862	0.0087	CbGpPWpGaD
Goserelin—Chest pain—Etoposide—brain cancer	0.000857	0.00118	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000851	0.00117	CcSEcCtD
Goserelin—Discomfort—Etoposide—brain cancer	0.000846	0.00116	CcSEcCtD
Goserelin—Feeling abnormal—Temozolomide—brain cancer	0.000846	0.00116	CcSEcCtD
Goserelin—Abdominal pain—Carmustine—brain cancer	0.000839	0.00115	CcSEcCtD
Goserelin—Body temperature increased—Carmustine—brain cancer	0.000839	0.00115	CcSEcCtD
Goserelin—Gastrointestinal pain—Temozolomide—brain cancer	0.000839	0.00115	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—STRADA—brain cancer	0.000837	0.00845	CbGpPWpGaD
Goserelin—Vomiting—Hydroxyurea—brain cancer	0.000835	0.00115	CcSEcCtD
Goserelin—Rash—Hydroxyurea—brain cancer	0.000828	0.00114	CcSEcCtD
Goserelin—Confusional state—Etoposide—brain cancer	0.000828	0.00114	CcSEcCtD
Goserelin—Dermatitis—Hydroxyurea—brain cancer	0.000827	0.00114	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—TRPC6—brain cancer	0.000824	0.00832	CbGpPWpGaD
Goserelin—Headache—Hydroxyurea—brain cancer	0.000823	0.00113	CcSEcCtD
Goserelin—Anaphylactic shock—Etoposide—brain cancer	0.000821	0.00113	CcSEcCtD
Goserelin—Infection—Etoposide—brain cancer	0.000816	0.00112	CcSEcCtD
Goserelin—Urticaria—Temozolomide—brain cancer	0.000815	0.00112	CcSEcCtD
Goserelin—Abdominal pain—Temozolomide—brain cancer	0.000811	0.00111	CcSEcCtD
Goserelin—Body temperature increased—Temozolomide—brain cancer	0.000811	0.00111	CcSEcCtD
Goserelin—Thrombocytopenia—Etoposide—brain cancer	0.000804	0.0011	CcSEcCtD
Goserelin—Tachycardia—Etoposide—brain cancer	0.000801	0.0011	CcSEcCtD
Goserelin—Skin disorder—Etoposide—brain cancer	0.000798	0.00109	CcSEcCtD
Goserelin—Hyperhidrosis—Etoposide—brain cancer	0.000794	0.00109	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ABR—brain cancer	0.000791	0.00799	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DTX2—brain cancer	0.000786	0.00794	CbGpPWpGaD
Goserelin—Anorexia—Etoposide—brain cancer	0.000783	0.00107	CcSEcCtD
Goserelin—Hypersensitivity—Carmustine—brain cancer	0.000782	0.00107	CcSEcCtD
Goserelin—Nausea—Hydroxyurea—brain cancer	0.00078	0.00107	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—SHH—brain cancer	0.000776	0.00783	CbGpPWpGaD
Goserelin—Hypotension—Etoposide—brain cancer	0.000767	0.00105	CcSEcCtD
Goserelin—Asthenia—Carmustine—brain cancer	0.000762	0.00105	CcSEcCtD
Goserelin—Hypersensitivity—Temozolomide—brain cancer	0.000756	0.00104	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—TRPC6—brain cancer	0.000748	0.00755	CbGpPWpGaD
Goserelin—Paraesthesia—Etoposide—brain cancer	0.000737	0.00101	CcSEcCtD
Goserelin—Asthenia—Temozolomide—brain cancer	0.000736	0.00101	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—SMO—brain cancer	0.000736	0.00743	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTCH1—brain cancer	0.000736	0.00743	CbGpPWpGaD
Goserelin—Dyspnoea—Etoposide—brain cancer	0.000732	0.001	CcSEcCtD
Goserelin—Somnolence—Etoposide—brain cancer	0.00073	0.001	CcSEcCtD
Goserelin—Diarrhoea—Carmustine—brain cancer	0.000727	0.000997	CcSEcCtD
Goserelin—Pruritus—Temozolomide—brain cancer	0.000726	0.000996	CcSEcCtD
Goserelin—Decreased appetite—Etoposide—brain cancer	0.000714	0.000979	CcSEcCtD
Goserelin—Fatigue—Etoposide—brain cancer	0.000708	0.000971	CcSEcCtD
Goserelin—Dizziness—Carmustine—brain cancer	0.000702	0.000964	CcSEcCtD
Goserelin—Constipation—Etoposide—brain cancer	0.000702	0.000964	CcSEcCtD
Goserelin—Pain—Etoposide—brain cancer	0.000702	0.000964	CcSEcCtD
Goserelin—Diarrhoea—Temozolomide—brain cancer	0.000702	0.000963	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ABR—brain cancer	0.000698	0.00705	CbGpPWpGaD
Goserelin—Dizziness—Temozolomide—brain cancer	0.000679	0.000931	CcSEcCtD
Goserelin—Feeling abnormal—Etoposide—brain cancer	0.000677	0.000928	CcSEcCtD
Goserelin—Vomiting—Carmustine—brain cancer	0.000675	0.000926	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GLI2—brain cancer	0.000674	0.00681	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Etoposide—brain cancer	0.000671	0.000921	CcSEcCtD
Goserelin—Rash—Carmustine—brain cancer	0.00067	0.000919	CcSEcCtD
Goserelin—Dermatitis—Carmustine—brain cancer	0.000669	0.000918	CcSEcCtD
Goserelin—Headache—Carmustine—brain cancer	0.000665	0.000913	CcSEcCtD
Goserelin—Vomiting—Temozolomide—brain cancer	0.000652	0.000895	CcSEcCtD
Goserelin—Urticaria—Etoposide—brain cancer	0.000652	0.000895	CcSEcCtD
Goserelin—Body temperature increased—Etoposide—brain cancer	0.000649	0.000891	CcSEcCtD
Goserelin—Abdominal pain—Etoposide—brain cancer	0.000649	0.000891	CcSEcCtD
Goserelin—Rash—Temozolomide—brain cancer	0.000647	0.000888	CcSEcCtD
Goserelin—Dermatitis—Temozolomide—brain cancer	0.000646	0.000887	CcSEcCtD
Goserelin—Headache—Temozolomide—brain cancer	0.000643	0.000882	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GLI1—brain cancer	0.000634	0.0064	CbGpPWpGaD
Goserelin—Nausea—Carmustine—brain cancer	0.000631	0.000865	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—VAV1—brain cancer	0.000617	0.00623	CbGpPWpGaD
Goserelin—Nausea—Temozolomide—brain cancer	0.00061	0.000836	CcSEcCtD
Goserelin—Hypersensitivity—Etoposide—brain cancer	0.000605	0.00083	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SUFU—brain cancer	0.000601	0.00607	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTCH2—brain cancer	0.000596	0.00601	CbGpPWpGaD
Goserelin—Asthenia—Etoposide—brain cancer	0.000589	0.000808	CcSEcCtD
Goserelin—Pruritus—Etoposide—brain cancer	0.000581	0.000797	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GFAP—brain cancer	0.00058	0.00586	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HES5—brain cancer	0.000577	0.00582	CbGpPWpGaD
Goserelin—Diarrhoea—Etoposide—brain cancer	0.000562	0.000771	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—VAV1—brain cancer	0.000561	0.00566	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STRADA—brain cancer	0.00056	0.00565	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—TRPC6—brain cancer	0.000552	0.00557	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HEY1—brain cancer	0.00055	0.00555	CbGpPWpGaD
Goserelin—Dizziness—Etoposide—brain cancer	0.000543	0.000745	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—DLL1—brain cancer	0.000539	0.00544	CbGpPWpGaD
Goserelin—Vomiting—Etoposide—brain cancer	0.000522	0.000716	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—SHH—brain cancer	0.000519	0.00524	CbGpPWpGaD
Goserelin—Rash—Etoposide—brain cancer	0.000518	0.00071	CcSEcCtD
Goserelin—Dermatitis—Etoposide—brain cancer	0.000517	0.00071	CcSEcCtD
Goserelin—Headache—Etoposide—brain cancer	0.000514	0.000706	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—TRPC6—brain cancer	0.000501	0.00506	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—SMO—brain cancer	0.000492	0.00497	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTCH1—brain cancer	0.000492	0.00497	CbGpPWpGaD
Goserelin—Nausea—Etoposide—brain cancer	0.000488	0.000669	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ABR—brain cancer	0.000467	0.00472	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SHH—brain cancer	0.000458	0.00463	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLI2—brain cancer	0.000451	0.00456	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000443	0.00447	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TRPC6—brain cancer	0.000442	0.00446	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SMO—brain cancer	0.000435	0.00439	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTCH1—brain cancer	0.000435	0.00439	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GLI1—brain cancer	0.000424	0.00429	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—VAV1—brain cancer	0.000413	0.00417	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SUFU—brain cancer	0.000402	0.00406	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CG—brain cancer	0.000392	0.00396	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GFAP—brain cancer	0.000388	0.00392	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—VAV1—brain cancer	0.000375	0.00379	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HEY1—brain cancer	0.000368	0.00372	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DLL1—brain cancer	0.000361	0.00364	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CG—brain cancer	0.000356	0.00359	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH2—brain cancer	0.000347	0.00351	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VAV1—brain cancer	0.000331	0.00334	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SHH—brain cancer	0.000307	0.0031	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TRPC6—brain cancer	0.000296	0.00299	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTCH1—brain cancer	0.000291	0.00294	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SMO—brain cancer	0.000291	0.00294	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HES1—brain cancer	0.000285	0.00288	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2—brain cancer	0.000276	0.00279	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFRA—brain cancer	0.000271	0.00274	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPP1—brain cancer	0.000263	0.00266	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CG—brain cancer	0.000262	0.00265	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—brain cancer	0.00025	0.00253	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CG—brain cancer	0.000238	0.00241	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS2—brain cancer	0.000238	0.0024	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH2—brain cancer	0.000233	0.00235	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VAV1—brain cancer	0.000222	0.00224	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CG—brain cancer	0.00021	0.00212	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APC—brain cancer	0.00021	0.00212	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—brain cancer	0.000192	0.00193	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HES1—brain cancer	0.000191	0.00193	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2—brain cancer	0.000185	0.00186	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFRA—brain cancer	0.000182	0.00183	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—brain cancer	0.000176	0.00178	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—brain cancer	0.000168	0.00169	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RELA—brain cancer	0.000164	0.00166	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB2—brain cancer	0.000163	0.00165	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS2—brain cancer	0.000159	0.00161	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2—brain cancer	0.000148	0.00149	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCND1—brain cancer	0.000144	0.00146	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CTNNB1—brain cancer	0.000143	0.00144	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APC—brain cancer	0.000141	0.00142	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CG—brain cancer	0.000141	0.00142	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—brain cancer	0.000128	0.00129	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—brain cancer	0.000126	0.00127	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—brain cancer	0.000125	0.00126	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—brain cancer	0.000116	0.00117	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—brain cancer	0.000113	0.00114	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RELA—brain cancer	0.00011	0.00111	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB2—brain cancer	0.000109	0.0011	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—brain cancer	9.91e-05	0.001	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—brain cancer	9.66e-05	0.000975	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CTNNB1—brain cancer	9.56e-05	0.000966	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—brain cancer	9.5e-05	0.000959	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—brain cancer	8.42e-05	0.00085	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—brain cancer	8.34e-05	0.000842	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—brain cancer	7.75e-05	0.000782	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—brain cancer	7.58e-05	0.000765	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—brain cancer	6.36e-05	0.000642	CbGpPWpGaD
